What we are reading Pharma Industry Seizes on Pandemic as a Shot at Redemption By ProMarket writers July 6, 2020 Share FacebookTwitterEmail ProMarket writers Popular This Week The Myth That Lobbying and Campaign Giving Are the Same The Warner Bros. Discovery Bidding War Shows Antitrust Enforcement Still Works Smart Contracts Are Shifting Property Rights and Risk How Competition Has Increased Fraud in Medicare’s DME Program No related posts. TagsFinancial Times Share FacebookTwitterEmail Previous articleChina Stocks Surge After State Media Urges Investors to Load UpNext articleAd Boycotts Alone Will Not Curb Big Tech LATEST NEWS The Warner Bros. Discovery Bidding War Shows Antitrust Enforcement Still Works How Competition Has Increased Fraud in Medicare’s DME Program How Bans on Corporate Political Donations Influence Campaign Platforms Smart Contracts Are Shifting Property Rights and Risk The Myth That Lobbying and Campaign Giving Are the Same Meta’s Winning Market Definition in Its Monopoly Case Relied on a Flawed Empirical Assumption Everyone Wants Competition. Few Ask What Kind Sharing a Leader With Your Rival Firm Increases Odds of Collusion Do Pharmaceutical Acquisitions Undermine Innovation by Disrupting Human Capital? Mass Shootings Do Not Change How US Politicians Vote on Gun Policy